Jiangsu Hengrui Medicine
600276.SS
#436
Rank
โ‚ฌ47.19 B
Marketcap
7,11ย โ‚ฌ
Share price
-0.87%
Change (1 day)
19.91%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Market capitalization of Jiangsu Hengrui Medicine (600276.SS)

Market cap: โ‚ฌ47.19 Billion

As of February 2026 Jiangsu Hengrui Medicine has a market cap of โ‚ฌ47.19 Billion. This makes Jiangsu Hengrui Medicine the world's 436th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jiangsu Hengrui Medicine from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ47.19 B-4.16%
2025โ‚ฌ49.24 B27.16%
2024โ‚ฌ38.72 B5.3%
2023โ‚ฌ36.77 B11.94%
2022โ‚ฌ32.85 B-26.9%
2021โ‚ฌ44.94 B-39.33%
2020โ‚ฌ74.07 B49.76%
2019โ‚ฌ49.46 B100.36%
2018โ‚ฌ24.68 B-0.43%
2017โ‚ฌ24.79 B69.58%
2016โ‚ฌ14.62 B7.81%
2015โ‚ฌ13.56 B81.17%
2014โ‚ฌ7.48 B21.09%
2013โ‚ฌ6.18 B36.96%
2012โ‚ฌ4.51 B11.73%
2011โ‚ฌ4.03 B-20.41%
2010โ‚ฌ5.07 B52.4%
2009โ‚ฌ3.33 B59.23%
2008โ‚ฌ2.09 B-8.82%
2007โ‚ฌ2.29 B120.62%
2006โ‚ฌ1.03 B164.12%
2005โ‚ฌ0.39 B38.78%
2004โ‚ฌ0.28 B37.95%
2003โ‚ฌ0.20 B-30.53%
2002โ‚ฌ0.29 B-39.95%
2001โ‚ฌ0.49 B-4.05%
2000โ‚ฌ0.51 B